CanSino Biologics, Inc. Class H (HK:6185) has released an update.
CanSino Biologics Inc. has entered into two structured deposit agreements with CBHB on May 21, 2024, for a total of RMB 160 million, which are considered discloseable transactions under the Hong Kong Listing Rules. The deposits, offering an expected maximum annualized return of up to 2.7%, were funded by internal resources and mature structured deposits, excluding the proceeds from the company’s H Share IPO. These transactions are aggregated for reporting due to their similar nature and the same counterparty involved.
For further insights into HK:6185 stock, check out TipRanks’ Stock Analysis page.
